Hongmeng Su

机构：Fujian Medical University, First Affiliated Hospital of Fujian Medical University · ORCID：0000-0002-3175-4097

发表论文 10 篇 · 总被引 141 次 · h-index 6

代表论文

• TRERNA1 upregulation mediated by HBx promotes sorafenib resistance and cell proliferation in HCC via targeting NRAS by sponging miR-22-3p (2021 · Molecular Therapy · 被引 61)
• Suppression of NSUN2 enhances the sensitivity to chemosensitivity and inhibits proliferation by mediating cell apoptosis in gastric cancer (2023 · Pathology - Research and Practice · 被引 21)
• Identification of ALYREF in pan cancer as a novel cancer prognostic biomarker and potential regulatory mechanism in gastric cancer (2024 · Scientific Reports · 被引 17)
• Targeting LEF1-mediated epithelial-mesenchymal transition reverses lenvatinib resistance in hepatocellular carcinoma (2024 · Investigational New Drugs · 被引 14)
• miRNA‑mRNA network contributes to HBV‑related hepatocellular carcinoma via immune infiltration induced by GRB2 (2024 · Biomedical Reports · 被引 11)
• ETV4 facilitates angiogenesis in hepatocellular carcinoma by upregulating MMP14 expression (2023 · Biochemical and Biophysical Research Communications · 被引 10)